674 related articles for article (PubMed ID: 30630438)
1. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
[TBL] [Abstract][Full Text] [Related]
2. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
[TBL] [Abstract][Full Text] [Related]
3. Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria.
Eide IA; Halden TA; Hartmann A; Åsberg A; Dahle DO; Reisaeter AV; Jenssen T
Transpl Int; 2016 May; 29(5):568-78. PubMed ID: 26875590
[TBL] [Abstract][Full Text] [Related]
4. Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus.
Eide IA; Halden TA; Hartmann A; Åsberg A; Dahle DO; Reisæter AV; Jenssen T
Transplantation; 2015 Mar; 99(3):629-35. PubMed ID: 25162478
[TBL] [Abstract][Full Text] [Related]
5. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
6. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
7. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin.
Yates CJ; Fourlanos S; Colman PG; Cohney SJ
Transplantation; 2013 Oct; 96(8):726-31. PubMed ID: 23902993
[TBL] [Abstract][Full Text] [Related]
8. Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial.
Kurnikowski A; Nordheim E; Schwaiger E; Krenn S; Harreiter J; Kautzky-Willer A; Leutner M; Werzowa J; Tura A; Budde K; Eller K; Pascual J; Krebs M; Jenssen TG; Hecking M
Am J Transplant; 2022 Dec; 22(12):2880-2891. PubMed ID: 36047565
[TBL] [Abstract][Full Text] [Related]
9. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
Davidson MB; Schriger DL; Peters AL; Lorber B
JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
[TBL] [Abstract][Full Text] [Related]
11. Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy.
Bergrem HA; Valderhaug TG; Hartmann A; Hjelmesaeth J; Leivestad T; Bergrem H; Jenssen T
Clin J Am Soc Nephrol; 2010 Apr; 5(4):616-22. PubMed ID: 20133490
[TBL] [Abstract][Full Text] [Related]
12. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
Hage C; Lundman P; Rydén L; Mellbin L
Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
[TBL] [Abstract][Full Text] [Related]
14. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
[TBL] [Abstract][Full Text] [Related]
15. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
[TBL] [Abstract][Full Text] [Related]
16. Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipients.
Wang L; Huang J; Li Y; Shi K; Gao S; Zhao W; Zhang S; Ding C; Gao W
Endocrine; 2023 Jul; 81(1):58-66. PubMed ID: 37148416
[TBL] [Abstract][Full Text] [Related]
17. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
[TBL] [Abstract][Full Text] [Related]
18. Pretransplantation Oral Glucose Tolerance Test Can Prevent Posttransplant Diabetes Mellitus After Renal Transplantation: Preliminary Study.
Hap K; Madziarska K; Zmonarski S; Kamińska D; Magott-Procelewska M; Banasik M; Jędrzejak K; Madziarski M; Hap W; Klinger M; Mazanowska O
Transplant Proc; 2018; 50(6):1776-1780. PubMed ID: 30056899
[TBL] [Abstract][Full Text] [Related]
19. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation.
Shabir S; Jham S; Harper L; Ball S; Borrows R; Sharif A
Transpl Int; 2013 Mar; 26(3):315-21. PubMed ID: 23279163
[TBL] [Abstract][Full Text] [Related]
20. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
